Attention Deficit Disorder with Hyperactivity  >>  ispronicline (AZD3480)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ispronicline (AZD3480) / AstraZeneca
NCT00683462: An Exploratory Trial of AZD3480 (TC-1734) for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD)

Completed
2
24
US
Placebo, AZD3480
AstraZeneca, Targacept Inc.
ADHD
 
07/09

Download Options